Key Takeaway:
Three professional, evidence-based powder mixes have been formulated for twice-daily use in CABG (Coronary Artery Bypass Graft) patients:
- CABG1 Cardio-Protective (cardiovascular/antioxidant focus)
- CABG2 Immune-Recovery (immune support and muscle preservation)
- Diabetic CABG (glucose-controlled immune support for diabetic patients)
Each mix is precisely dosed, clinically justified, and includes professional labeling, contraindications, and implementation guidance.
Based on the latest clinical evidence and expert consensus, here are three professional powder mix formulations for CABG patients, designed for twice-daily administration. Each formula targets a specific perioperative need—cardiovascular protection, immune/muscle recovery, and diabetic safety. All dosing, ingredient selection, and safety measures are grounded in peer-reviewed research and meta-analyses from 2020–2025.
Purpose:
Reduce cardiovascular mortality, arrhythmias, and oxidative stress in CABG patients.
Serving Size: 6.3 g (2x daily; total 12.6 g/day)
Administration: Mix with 8–12 oz water or shake, take with morning and evening meals.
| Active Ingredient | Per Serving | Form | Clinical Rationale |
|---|---|---|---|
| Coenzyme Q10 | 75 mg | Ubiquinol (oil-encapsulated) | ↓ CV mortality, arrhythmias |
| Selenium | 0.1 mg | Sodium selenite | Antioxidant synergy with CoQ10 |
| Omega-3 fatty acids | 1000 mg | EPA/DHA concentrate | ↓ Atrial fibrillation, inflammation |
| L-Arginine | 3500 mg | L-Arginine HCl | Endothelial/NO support, synergy w/CoQ10 |
| L-Carnitine | 750 mg | Acetyl-L-Carnitine | Mitochondrial/cardiac support |
| Vitamin C | 250 mg | Ascorbic acid | Antioxidant, redox cycling |
| Vitamin E | 100 mg | Mixed tocopherols | Antioxidant, supports CoQ10 |
| Magnesium | 200 mg | Magnesium bisglycinate | Electrolyte, enzyme cofactor |
Macronutrients per serving:
Contraindications:
Professional Labeling & Rationale:
Purpose:
Enhance immune function, preserve muscle, and support wound healing post-CABG.
Serving Size: 14.5 g (2x daily; total 29.0 g/day)
Administration: Mix with 12–16 oz liquid, take with meals.
| Active Ingredient | Per Serving | Form | Clinical Rationale |
|---|---|---|---|
| Omega-3 fatty acids | 1000 mg | EPA/DHA concentrate | ↓ Inflammation, immune modulation |
| L-Arginine | 3500 mg | L-Arginine HCl | Immune/wound healing, NO synthesis |
| L-Glutamine | 7500 mg | L-Glutamine free form | Immune/gut barrier support |
| HMB | 1500 mg | Ca-HMB | Muscle preservation |
| Zinc | 10 mg | Zinc bisglycinate | Wound healing, immune support |
Macronutrients per serving:
Contraindications:
Professional Labeling & Rationale:
Purpose:
Provide immune and muscle support for diabetic CABG patients while minimizing glycemic impact.
Serving Size: 13.1 g (2x daily; total 26.2 g/day)
Administration: Mix with main meals, coordinate with diabetes management.
| Active Ingredient | Per Serving | Form | Clinical Rationale |
|---|---|---|---|
| L-Arginine | 3200 mg | L-Arginine HCl | Insulin sensitivity, immune support |
| L-Glutamine | 7500 mg | L-Glutamine free form | Immune/gut barrier support |
| HMB | 1500 mg | Ca-HMB | Muscle preservation, glucose metabolism |
Macronutrients per serving:
Contraindications:
Professional Labeling & Rationale:
| Parameter | CABG1 (Cardio-Protective) | CABG2 (Immune-Recovery) | Diabetic CABG |
|---|---|---|---|
| Target Population | All CABG patients | High-risk/elderly CABG | Diabetic CABG patients |
| Primary Indication | CV mortality reduction | Immune/muscle support | Glucose-controlled support |
| Serving Size (g) | 6.3 | 14.5 | 13.1 |
| Daily Intake (g) | 12.6 | 29.0 | 26.2 |
| Protein per Serving (g) | 3.5 | 11.0 | 10.7 |
| Fat per Serving (g) | 1.0 | 1.0 | 0.0 |
| Key Actives | CoQ10, Selenium, Omega-3 | Arginine, Glutamine, HMB | Arginine, Glutamine, HMB |
| Evidence Level | Strong (RCTs/meta-analyses) | Strong | Strong (diabetic-specific) |
| Pre-op Duration | 7–10 days | 5–7 days | 5–7 days |
| Post-op Duration | 4–6 weeks | 2–4 weeks | 2–4 weeks |
Comparative macronutrient and active ingredient profiles per serving for each formulation.
Each formulation includes:
Key Finding:
These formulations are designed for professional healthcare provider supervision and are not intended for general consumer use. They are tailored to optimize perioperative outcomes in CABG patients, with specific modifications for diabetic safety and immune support.
All mixes are to be used twice daily under professional supervision, with clear contraindications and monitoring protocols. These evidence-based formulations are ready for clinical implementation to improve CABG patient outcomes.